Suspended closer Jose Alvarado leaves Phillies in crisis

In May 2025, the Philadelphia Phillies faced a significant challenge when closer Jose Alvarado was suspended for 80 games after testing positive for exogenous testosterone, a banned performance-enhancing substance. This suspension left a substantial void in the bullpen, as Alvarado has been a crucial component of the team's pitching staff, known for his triple-digit velocity and effectiveness as a late-inning reliever. Phillies president of baseball operations Dave Dombrowski expressed disappointment and acknowledged the team's need to adapt quickly to this setback. With the injury to Aaron Nola and Alvarado's absence, the Phillies will lean on youngsters and existing bullpen arms as they strive to defend their NL East title amidst a tightening competition in the division. Matt Strahm and Tanner Banks are among the options available, but questions remain about the long-term capability of the bullpen without a reliable closer. This suspension has also put Alvarado's future club option for 2026 into jeopardy, creating an environment of uncertainty as the team decides how to proceed. Meanwhile, Alvarado himself, unaware that he was taking a prohibited substance, has accepted the suspension and is not appealing the decision. The team remains hopeful that returning injured players and potential trades will bolster the roster as they navigate this crisis.